These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38447251)
1. Prognostic factors in high-grade pediatric osteosarcoma among children and young adults: Greek Nationwide Registry for Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST) data along with a systematic review and meta-analysis. Papakonstantinou E; Athanasiadou KI; Markozannes G; Tzotzola V; Bouka E; Baka M; Moschovi M; Polychronopoulou S; Hatzipantelis E; Galani V; Stefanaki K; Strantzia K; Vousvouki M; Kourou P; Magkou E; Nikita M; Zambakides C; Michelarakis J; Alexopoulou A; Gavra M; Malama A; Ntzani EE; Petridou ET Cancer Epidemiol; 2024 Jun; 90():102551. PubMed ID: 38447251 [TBL] [Abstract][Full Text] [Related]
2. A Novel System for the Surgical Staging of Primary High-grade Osteosarcoma: The Birmingham Classification. Jeys LM; Thorne CJ; Parry M; Gaston CL; Sumathi VP; Grimer JR Clin Orthop Relat Res; 2017 Mar; 475(3):842-850. PubMed ID: 27138473 [TBL] [Abstract][Full Text] [Related]
3. Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma. Tsuda Y; Tsoi K; Parry MC; Stevenson JD; Fujiwara T; Sumathi V; Jeys LM Bone Joint J; 2020 Jun; 102-B(6):795-803. PubMed ID: 32475245 [TBL] [Abstract][Full Text] [Related]
4. Sex differences in osteosarcoma survival across the age spectrum: A National Cancer Database analysis (2004-2016). Williams LA; Barragan S; Lu Z; Weigel BJ; Spector LG Cancer Epidemiol; 2024 Oct; 92():102565. PubMed ID: 38575425 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma? Xu J; Xie L; Guo W Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746 [TBL] [Abstract][Full Text] [Related]
6. [Results of the treatment of pediatric osteosarcoma in the Hungarian population]. Hegyi M; Félné Semsei A; Jakab Z; Antal I; Kiss J; Szendrõi M; Csóka M; Kovács G Magy Onkol; 2012 Mar; 56(1):30-7. PubMed ID: 22403760 [TBL] [Abstract][Full Text] [Related]
7. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma. Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555 [TBL] [Abstract][Full Text] [Related]
8. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt. Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367 [TBL] [Abstract][Full Text] [Related]
9. Osteosarcoma in patients younger than 12 years old without metastases have similar prognosis as adolescent and young adults. Eleutério SJ; Senerchia AA; Almeida MT; Da Costa CM; Lustosa D; Calheiros LM; Barreto JH; Brunetto AL; Macedo CR; Petrilli AS Pediatr Blood Cancer; 2015 Jul; 62(7):1209-13. PubMed ID: 25755160 [TBL] [Abstract][Full Text] [Related]
10. A study of 853 high grade osteosarcomas from a single institution-Are outcomes in Indian patients different? Puri A; Byregowda S; Gulia A; Crasto S; Chinaswamy G J Surg Oncol; 2018 Feb; 117(2):299-306. PubMed ID: 28833209 [TBL] [Abstract][Full Text] [Related]
11. Beyond 5-year survival. A report from the Cooperative Osteosarcoma Study Group (COSS). Fernandes JS; Blattmann C; Hecker-Nolting S; Kager L; Kevric M; Mettmann V; Sorg B; Fernandes M; Bielack SS Cancer Med; 2024 Jan; 13(1):e6893. PubMed ID: 39102672 [TBL] [Abstract][Full Text] [Related]
12. The outcomes and prognostic factors in patients with osteosarcoma according to age: a Japanese nationwide study with focusing on the age differences. Tsuda Y; Ogura K; Shinoda Y; Kobayashi H; Tanaka S; Kawai A BMC Cancer; 2018 May; 18(1):614. PubMed ID: 29855362 [TBL] [Abstract][Full Text] [Related]
13. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma? Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141 [TBL] [Abstract][Full Text] [Related]
14. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial. Bielack SS; Smeland S; Whelan JS; Marina N; Jovic G; Hook JM; Krailo MD; Gebhardt M; Pápai Z; Meyer J; Nadel H; Randall RL; Deffenbaugh C; Nagarajan R; Brennan B; Letson GD; Teot LA; Goorin A; Baumhoer D; Kager L; Werner M; Lau CC; Sundby Hall K; Gelderblom H; Meyers P; Gorlick R; Windhager R; Helmke K; Eriksson M; Hoogerbrugge PM; Schomberg P; Tunn PU; Kühne T; Jürgens H; van den Berg H; Böhling T; Picton S; Renard M; Reichardt P; Gerss J; Butterfass-Bahloul T; Morris C; Hogendoorn PC; Seddon B; Calaminus G; Michelagnoli M; Dhooge C; Sydes MR; Bernstein M; J Clin Oncol; 2015 Jul; 33(20):2279-87. PubMed ID: 26033801 [TBL] [Abstract][Full Text] [Related]
15. Incidence patterns of childhood non-Wilms renal tumors: Comparing data of the Nationwide Registry of Childhood Hematological Malignancies and Solid Tumors (NARECHEM-ST), Greece, and the Surveillance, Epidemiology, and End Results Program (SEER), USA. Doganis D; Karalexi MA; ; Panagopoulou P; Bouka P; Bouka E; Markozannes G; Ntzani EE; Steliarova-Foucher E; Petridou ET Cancer Epidemiol; 2022 Jun; 78():102153. PubMed ID: 35390585 [TBL] [Abstract][Full Text] [Related]
16. Incidence and survival rates among pediatric osteogenic sarcoma cases in Khon Kaen, Thailand, 1985-2010. Wiromrat P; Jetsrisuparb A; Komvilaisak P; Sirichativapee W; Kamsa-Ard S; Wiangnon S Asian Pac J Cancer Prev; 2012; 13(9):4281-4. PubMed ID: 23167328 [TBL] [Abstract][Full Text] [Related]
17. Poor survival for osteosarcoma of the pelvis: a report from the Children's Oncology Group. Isakoff MS; Barkauskas DA; Ebb D; Morris C; Letson GD Clin Orthop Relat Res; 2012 Jul; 470(7):2007-13. PubMed ID: 22354612 [TBL] [Abstract][Full Text] [Related]
18. Predictors and Treatment Outcomes of Pediatric Osteosarcoma in Diverse Socioeconomic Backgrounds in Southeast Asia: A Retrospective Multicenter Study. Monsereenusorn C; Alcasabas AP; Loh AHP; Soh SY; Leung KWP; Dhamne C; Blair S; Lam C; Rujkijyanont P; Traivaree C; Photia A; Veerapan P; Puhaindran ME; Oh BLZ; Wang E; Rodriguez-Galindo C Asian Pac J Cancer Prev; 2022 Feb; 23(2):631-640. PubMed ID: 35225476 [TBL] [Abstract][Full Text] [Related]
19. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients. Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458 [TBL] [Abstract][Full Text] [Related]
20. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan. Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]